Interleukin-5 Antagonist Monoclonal Antibody Therapy Improves Symptoms and Reduces Steroid Dependence in Eosinophilic Myocarditis Patients

Interleukin-5 Antagonist Monoclonal Antibody Therapy Improves Symptoms and Reduces Steroid Dependence in Eosinophilic Myocarditis Patients

Eosinophilic myocarditis (EM) is a rare disease associated with significant morbidity and mortality. This case series follows the clinical courses of 3 patients with EM. The use of mepolizumab, an anti–interleukin-5 monoclonal antibody, as an adjunctive treatment was associated with stabilization of...

Full description

Bibliographic Details
Main Authors: Vincenzo Trovato, MD, Ashlee Asada, MD, Lynn Fussner, MD, Casey Curtis, MD, Rami Kahwash, MD
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:JACC: Case Reports
Subjects:
eosinophilic myocarditis
interleukin-5
myocarditis
reduced ejection fraction
steroid-sparing
Online Access:http://www.sciencedirect.com/science/article/pii/S2666084924000482

Internet

http://www.sciencedirect.com/science/article/pii/S2666084924000482

Similar Items